# Susana Puig

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/susana-puig/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,087 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 91 |
| i10-index | 450 |
| Last Known Institution | Instituto de Salud Carlos III |
| OpenAlex ID | https://openalex.org/A5079760997 |
| ORCID iD | https://orcid.org/0000-0003-1337-9745 |
| Works | 896 |

## Researcher papers

- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet](https://scholariq.org/papers/dermoscopy-of-pigmented-skin-lesions-results-of-a-consensus-meeting-via-the/)
- [Human–computer collaboration for skin cancer recognition](https://scholariq.org/papers/human-computer-collaboration-for-skin-cancer-recognition/)
- [Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study](https://scholariq.org/papers/comparison-of-the-accuracy-of-human-readers-versus-machine-learning-algorithms/)
- [Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma-eortc-1325/)
- [Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial](https://scholariq.org/papers/cemiplimab-in-locally-advanced-basal-cell-carcinoma-after-hedgehog-inhibitor/)
- [ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee](https://scholariq.org/papers/esmo-consensus-conference-recommendations-on-the-management-of-metastatic/)
- [Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non‐neoplastic dermatoses): an expert consensus on behalf of the International Dermoscopy Society](https://scholariq.org/papers/standardization-of-dermoscopic-terminology-and-basic-dermoscopic-parameters-to/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [melanin and skin pigmentation](https://scholariq.org/topics/melanin-and-skin-pigmentation/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)

## Researcher university

- [Instituto de Salud Carlos III](https://scholariq.org/institutions/instituto-de-salud-carlos-iii/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.